A Newcastle disease virus double plasmid rescue system and its construction method, identification method and application
By constructing a dual plasmid rescue system for Newcastle Disease Virus and using the genome of the full-length NDV LaSota strain and the helper plasmid PCI-NPL, the problem of plasmids entering cells at the same time in traditional systems was solved, significantly improving the efficiency of virus rescue and achieving more Efficient virus rescue.
Patent Information
- Application Number
- CN202310443379.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-24
- Publication Date
- 2024-11-01
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The traditional Newcastle virus rescue system requires multiple plasmids to enter the cell at the same time, resulting in inefficient rescue efficiency and high difficulty in rescue.
The Newcastle Virus dual plasmid rescue system was adopted to construct a dual plasmid system containing the genome of the full-length NDV LaSota strain and the helper plasmid PCI-NPL. The cells were co-transfected by calcium phosphate method to reduce the number of plasmids and improve the efficiency of virus rescue.
The rescue efficiency of Newcastle Disease Virus has been successfully improved, and the feasibility of the dual plasmid system has been proved, providing a simpler and more efficient method for the rescue of negative-strand RNA viruses. The rescue efficiency is 2.25 times that of the traditional four plasmid system.
Smart Images

Figure CN116479047B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of RNA virus reverse genetics, and in particular to a Newcastle disease virus double-plasmid rescue system, an identification method, and a construction method and application thereof. Background Art
[0002] Reverse genetics of RNA viruses is a method of artificially manipulating and modifying RNA viruses at the DNA level by constructing a cDNA molecular clone of the entire viral genome, and then obtaining infectious progeny viruses through in vitro transcription.
[0003] Newcastle disease virus (NDV) is a non-segmented negative-strand RNA virus of the genus Orthomyxovirinae, subfamily Paramyxoviridae. Its host range is almost all birds. Strong strains can cause damage to the entire circulatory system and central nervous system, which is seriously harmful to the breeding industry. Newcastle disease virus attenuated vaccine has extremely significant advantages as a virus vaccine vector, such as high safety, genetic stability, no integration with host genes, and convenient administration. The establishment of a virus rescue system based on reverse genetic manipulation technology is the material basis for realizing artificial virus modification.
[0004] Since the first Newcastle disease virus was successfully rescued in 1999, the Newcastle disease virus rescue system has undergone many improvements, from the initial need to pre-infect poxvirus expressing T7 RNA polymerase or construct a T7 RNA polymerase-dependent rescue system, to the use of RNA polymerase II widely present in eukaryotic cells, which only requires cloning genomic cDNA to the downstream of the CMV promoter of the eukaryotic expression vector, to easily and efficiently rescue the virus. The emergence of the RNA polymerase II reverse genetics operating system has greatly simplified the reverse genetics operation of negative-strand RNA viruses and enhanced the efficiency of virus rescue.
[0005] However, in the process of virus rescue, it is necessary to simulate the natural infection mechanism of Newcastle disease virus. The viral genome first needs to bind to nucleoprotein (NP), phosphoprotein (P), and polymerase protein (L) to form a ribonucleoprotein polymer (RNP), which is the smallest infection unit of the virus. The viral genome RNA is transcribed into positive-strand RNA, and the virus structural proteins are synthesized as a template to reassemble into new progeny virus particles. This requires the participation of at least the genome and three auxiliary proteins in the virus rescue process. In the past, a genome cDNA clone plasmid and three auxiliary plasmids were usually transfected, and the genome plasmid and three auxiliary plasmids must enter a cell at the same time for replication and expression to complete the assembly of the virus. Because the traditional four-plasmid rescue system has a high rescue difficulty, its rescue efficiency is low. Summary of the invention
[0006] The present invention aims to solve the problems of high rescue difficulty and low efficiency of the traditional four-plasmid rescue system, and proposes a Newcastle disease virus double-plasmid rescue system and a construction method thereof in order to increase the probability of plasmids entering the same cell, which has higher rescue efficiency.
[0007] In order to achieve the above object, the technical solution of the present invention is as follows:
[0008] In a first aspect, the present invention provides a method for constructing a Newcastle disease virus double plasmid rescue system, comprising the following steps:
[0009] S1. Construction of plasmid pCI-LaSota for full-length cloning of NDV LaSota strain genome:
[0010] According to the genome sequence of NDV LaSota strain, the whole genome was divided into 5 gene fragments with overlapping ends and cloned in segments, and the restriction enzyme sites of the overlapping parts of adjacent fragments were used to splice into the complete NDV LaSota strain genome full-length cDNA in vitro, and the hammerhead ribozyme sequence and the hepatitis D virus ribozyme sequence were introduced at the 5' end and 3' end, respectively, and cloned into the eukaryotic expression vector pCI to construct pCI-LaSota, whose nucleotide sequence is shown in SEQ No. 1;
[0011] S2. Construction of auxiliary plasmid PCI-NPL:
[0012] Using the cDNA in step S1 as a template, NP, P and L genes were amplified respectively, and the promoter and Poly A signal were fused to construct a three-promoter auxiliary plasmid PCI-NPL that can co-express NP, P and L proteins, and its nucleotide sequence is shown in SEQ No. 2;
[0013] S3. Construction of dual-plasmid rescue system:
[0014] The NDV LaSota strain genome full-length clone plasmid pCI-LaSota and auxiliary plasmid PCI-NPL were co-transfected into BHK-21 cells at a ratio of 2:1 using the calcium phosphate method. The transfected cell supernatant was harvested 5 days later and inoculated into the allantoic cavity of SPF chicken embryos. The virus allantoic fluid was harvested and the positive results of the HA test were recorded as rLaSota and stored.
[0015] Furthermore, in step S1, the NDV LaSota strain genome was first subjected to site-directed mutagenesis by PCR to mutate the 3155-3162nt sequence into a PmeⅠ restriction enzyme sequence, and then the LaSota genome was divided into five gene fragments according to the restriction sites PmeⅠ, XbaⅠ, BsiWⅠ, and StuⅠ in the genome. The amplified products of the five gene fragments were 3216bp, 3221bp, 3014bp, 2680bp, 3985bp, and 2437bp fragments, respectively.
[0016] Furthermore, in step S1, an MluⅠ restriction enzyme site is introduced upstream of the hammerhead ribozyme sequence, and a NotⅠ restriction enzyme site is introduced downstream of the hepatitis D virus ribozyme sequence. The MluⅠ and NotⅠ restriction enzyme sites are used to connect the entire genome into the pCI eukaryotic expression vector CMV promoter downstream between the MluⅠ and NotⅠ sites to construct the full-length genome plasmid pCI-LaSota.
[0017] Furthermore, in step S2, the cDNA in step S1 is used as a template to amplify the CDS regions of NP and P genes respectively, the L gene is amplified in two segments according to the XmaⅠ restriction enzyme site in the L gene, and the Kozak sequence GCCACC is introduced upstream of the CDS region of each gene.
[0018] Furthermore, in step S2, NheⅠ and NotⅠ restriction sites are introduced at both ends of NP and P genes, respectively, and XbaⅠ and NotⅠ restriction sites are introduced at both ends of L gene, respectively.
[0019] Further, in step S2, the amplified NP, P and L genes are connected to the multiple cloning site of the pCI expression vector, respectively, and are recorded as pCI-NP, pCI-P, and pCI-L; the NP and P genes are then connected to PolyA, respectively, to obtain NP-PolyA and P-PolyA, and the CMV part is connected to the 3' end of NP-PolyA and P-PolyA, respectively, by the fusion PCR method, to form NP-PolyA-CMV and P-PolyA-CMV structures; an MluⅠ restriction site is introduced upstream and a SacⅡ restriction site is introduced downstream of the NP-PolyA-CMV structure, and a SacⅡ restriction site is introduced upstream and a XbaⅠ restriction site is introduced downstream of the P-PolyA-CMV structure, and the corresponding restriction endonucleases are used for digestion, and the NP-PolyA-CMV structure and the P-PolyA-CMV structure are sequentially connected to the pCI-L vector MluⅠ, SacⅡ, and XbaⅠ by T4 ligase to construct a three-promoter auxiliary plasmid pCI-NPL.
[0020] Furthermore, the specific method of the dual plasmid rescue system in step S3 is:
[0021] Take 5μg pCI-LaSota, 2.5μg pCI-NPL and 9μL 2M CaCl2 solution and add them to a 1.5ml centrifuge tube. Add sterile H2O to 75μL, mix by inversion, and gradually transfer into 75μL of 2×Hepes Buffered Saline prepared in advance. After mixing everything, let it stand for 20min, add it to a BHK-21 six-well cell plate, and make sure the transfection mixture is evenly distributed on the cell surface. The cells are incubated at 5% After culturing in a CO2, 37°C incubator for 3 hours, the cells were placed in a 42°C water bath for heat shock for 2 hours and continued to be cultured in a cell culture incubator; 24 hours after transfection, the culture medium was discarded, PBS buffer containing 10% DMSO was added for cell shock, the liquid was discarded after 2.5 minutes, and complete DMEM culture medium was added to continue culturing in an incubator; 48 hours after transfection, serum-free DMEM was replaced and TPCK trypsin was added to a final concentration of 1 μg / mL; 96 hours after transfection, the cell supernatant was harvested, filtered through a 0.22 μM filter, and then inoculated into the allantoic cavity of 9-11-day-old SPF chicken embryos; 120 hours after transfection, the chicken embryo allantoic fluid was collected for a hemagglutination test, and the one with a positive test result was recorded as rLaSota.
[0022] In a second aspect, the present invention provides a Newcastle disease virus double plasmid rescue system obtained by any of the construction methods described above.
[0023] In a third aspect, the present invention provides a method for testing the above-mentioned Newcastle disease virus double plasmid rescue system, wherein the double plasmid system consisting of transcription plasmids pCI-LaSota-EGFP and pCI-NPL is co-transfected into BHK-21 cells at a ratio of 1:1 by calcium phosphate transfection method, and placed in a 42°C water bath for heat shock for 2 hours after transfection for 3 hours, and then cultured for 12 hours, and then using PBS containing 10% DMSO to shock the cells for 2.5 minutes, discarding the shock solution, adding complete DMEM to continue culturing for 24 hours, replacing the DMEM maintenance solution containing 2% serum, adding 1 μL of TPCK trypsin with a concentration of 1 μg / mL, and observing the presence of green fluorescent protein signals under a fluorescence microscope every day;
[0024] The method for constructing the transcription plasmid pCI-LaSota-EGFP is as follows: clone an expression cassette consisting of a transcription termination signal TTAGAAAAAA, a transcription start signal ACGGGTAGAA and an enhanced green fluorescent protein gene ORF, and insert it into the PmeⅠ restriction site between PM genes in the full-length cloning plasmid pCI-LaSota of the Newcastle disease virus LaSota strain genome to construct the transcription plasmid pCI-LaSota-EGFP.
[0025] In a fourth aspect, the present invention provides the use of the above-mentioned Newcastle disease virus double plasmid rescue system in constructing a recombinant Newcastle disease virus, wherein the recombinant Newcastle disease virus is a recombinant LaSota strain or a virus particle thereof.
[0026] Compared with the prior art, the technical effects of the present invention are:
[0027] The Newcastle disease virus double-plasmid rescue system provided by the invention constructs a Newcastle disease virus LaSota strain full genome cDNA cloning plasmid based on a CMV promoter, and constructs a multi-promoter single helper plasmid pCI-NPL capable of simultaneously expressing NP, P and L proteins, and finally constructs a double-plasmid rescue system, so as to reduce the number of transfected plasmids and increase the Newcastle disease virus rescue efficiency, and successfully produces infectious Newcastle disease virus progeny particles, thus proving the feasibility of the double-plasmid system and providing a new idea for constructing a simpler and more efficient rescue system for NDV and other negative-strand RNA viruses.
[0028] To verify the effectiveness of the dual-plasmid rescue system of the present invention as a NDV vector development platform, an expression cassette consisting of a transcription termination signal (TTAGAAAAAA), a transcription start signal (ACGGGTAGAA) and an enhanced green fluorescent protein (EGFP) gene ORF was cloned and inserted into the PmeⅠ restriction site between the PM genes of the NDV genome to construct a full-length genomic plasmid pCI-LaSota-EGFP. The dual-plasmid rescue system was used to successfully rescue the recombinant virus rLaSota-EGFP expressing EGFP, and an obvious spontaneous green fluorescent signal was observed by fluorescence microscopy, and the western blot results confirmed that GPF was correctly expressed. The rescue efficiency was evaluated based on the EGFP reporter gene, and the results showed that the rescue efficiency of the dual-plasmid system was higher than that of the traditional four-plasmid rescue system, which was 2.25 times that of the former. The results of hemagglutination titer, EID50, MDT, ICPI and IVPI tests showed that the recombinant viruses rLaSota and rLaSota-EGFP had similar biological characteristics (pathogenicity and chicken embryo growth characteristics) to the parental wild-type strains, laying the foundation for the rescue of Newcastle disease virus and other Paramyxoviridae viruses. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 The present invention provides a strategy for cloning the entire gene of the NDV LaSota strain.
[0030] Figure 2 The RT-CR amplification results of each segment of the LaSota genome provided in the embodiment of the present invention. M: DL5000 DNA molecular weight standard; F1-F: amplification results of each cDNA fragment.
[0031] Figure 3 The invention provides a method for constructing a full-length DNA clone plasmid of the NDV LaSota strain genome.
[0032] Figure 4A three-promoter auxiliary plasmid construction strategy provided in an embodiment of the present invention.
[0033] Figure 5 The pCI-NP, pCI-P, and pCI-NPL plasmid digestion identification results provided in the embodiments of the present invention. M1 and M2: DNA molecular weight standards of DL5000 and DL1000 respectively; 1: pCI-NP digestion product; 2: pCI-P digestion product; 3: pCI-L digestion product.
[0034] Figure 6 This is a Blunt-NPC and Blunt-PPC digestion identification diagram provided in the embodiments of the present invention. M: 5000bp molecular weight standard; 1: Blunt-NPC digestion; 2: Blunt-PPC digestion.
[0035] Figure 7 The results of double restriction enzyme digestion of the auxiliary plasmid pCI-NPL provided in the embodiment of the present invention: M: 15000 molecular weight standard; 1: pCI-NL plasmid; 2: pCI-NPL was digested into fragments of 10605 bp and 5132 bp.
[0036] Figure 8 The indirect immunofluorescence results of the helper plasmids pCI-NP, pCI-P, and pCI-L provided in the embodiments of the present invention.
[0037] Fig. 9 This is the indirect immunofluorescence identification result of the auxiliary plasmid pCI-NPL provided in the embodiment of the present invention.
[0038] Fig.10 The western blot provided in the embodiment of the present invention identifies the expression results of the auxiliary plasmid protein.
[0039] Fig.11 The results of the rLaSota hemagglutination test provided in the embodiments of the present invention.
[0040] Fig.12 This is the identification result of the rLaSota virus genetic marker provided by the embodiment of the present invention.
[0041] Fig.13 The results of indirect immunofluorescence detection of rescued virus rLaSota provided in the embodiment of the present invention.
[0042] Fig.14 This is a graph showing the chicken embryo replication kinetics of the recombinant virus provided in an embodiment of the present invention.
[0043] Fig.15 This is the rescue efficiency evaluation result of the dual-plasmid system provided in the embodiment of the present invention. DETAILED DESCRIPTION
[0044] In order to enable those skilled in the art to better understand the technical solution of the present invention, the present invention will be further described in detail below in conjunction with the embodiments and drawings. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the present invention. The experimental methods in the following embodiments are conventional methods unless otherwise specified. The test materials used in the following embodiments are purchased from conventional biochemical reagent stores unless otherwise specified. NDV LaSota strain was purchased from Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. BHK-21 cells and pCI empty vectors (Promage, Genbank: U47119) are both stored in the Animal Microecological Preparation Engineering Research Center of Jilin Agricultural University. SPF chicken embryos were purchased from the Experimental Animal Center of Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences.
[0045] Example 1 Construction of Newcastle Disease Virus Genome cDNA
[0046] (1) Extraction of Newcastle disease virus genomic RNA: 100 μL of NDV LaSota strain sample was placed in a 1.5 ml centrifuge tube, and total RNA was obtained from the sample according to the instructions of the total RNA extraction kit (BioFlux, BSC52M1).
[0047] (2) Reverse transcription: According to the instructions of the reverse transcription reagent (Novozyme, R211), first prepare the RNA denaturation reaction system (8 μL in total): 5 μL of total RNA extracted in the previous step, 1 μL of Oligo primer (50 μM) and 2 μL of RNase-free ddH2O, heat at 65°C for 5 min, and place on ice for 2 min to complete denaturation. Take 10 μL of 2×RT Mix and 2 μL of HiScript II Enzyme Mix and add them to the denaturation mixture in the previous step, react at 50°C for 45 min, and react at 85°C for 2 min to obtain the viral genome cDNA template, which is stored at -20°C for later use.
[0048] (3) Segmented amplification: Based on the restriction sites PmeⅠ (introduced by PCR mutation), XbaⅠ, BsiWⅠ and StuⅠ on the NDV genome sequence (Genbank: AF077761), the genome was divided into five segments of different lengths, denoted as F1-F5 ( Figure 1 ). DNA high-fidelity polymerase (Novozyme, P525-01) was used to amplify the F1-F5 fragments in vitro with genomic cDNA as a template. The primers used are shown in Table 1.
[0049] Table 1 Primers for constructing full-length cDNA clone of Newcastle disease LaSota strain genome
[0050]
[0051]
[0052] Note: The underlined part indicates the restriction site; the italic part is the hammerhead ribozyme (HamRz) sequence; the bold part is the hepatitis D virus ribozyme (HdvRz) sequence.
[0053] In order to obtain accurate genomic ends, hammerhead ribozyme (HamRZ) and MluⅠ restriction site were added to the 5' end of F1 fragment, and hepatitis D virus ribozyme structure (HdvRz) and NotⅠ restriction site were added to the 3' end of F5 fragment. Each target fragment was obtained and verified by agarose nucleic acid electrophoresis. The results of agarose gel electrophoresis showed ( Figure 2 ), the amplified products were 3216bp, 3014bp, 2680bp, 3985bp, and 2437bp fragments, which were the same as the expected results.
[0054] The amplified fragments were recovered by gel recovery kit (Kangwei reagent, CW2302M) and connected to 5×TA\Blunt-Zero (Novozyme, C601) blunt-end cloning vectors. DH5α competent cells (Takara) were melted on ice, 100μL was added to a round-bottom 2mL EP tube, 10μL of the ligation product was added, and the bottom of the tube was flicked to mix, and it was placed on ice for 30min, 42℃ water bath for 45s, and then placed on ice for 2min, and 700μL SOC culture medium was added and cultured on a shaking table at 37℃220rpm. After 1h, the transformation product was centrifuged at 5000rpm2min to the bottom of the tube, and 100μL SOC culture medium was left to resuspend the precipitate, which was spread on LB solid plate and grown for 12h. The positive single colony was picked and placed in LB liquid medium for overnight culture, and the plasmid was extracted and sequenced using a plasmid mini-extraction kit (Kangwei Century, CW0500). The sequencing results showed that the nucleotide sequence of each fragment was consistent with GenBank.
[0055] (4) F1-F5 ligation: According to the restriction enzyme sites at both ends of each fragment of F1-F5, they were cut out from the cloning vector in sequence by double enzyme digestion. The enzyme digestion system is shown in Table 3, and the reaction was carried out in a water bath at 37°C for 45 min. The F1-F5 fragments were connected in sequence by T4 ligase and cloned into the MluⅠ and NotⅠ sites of the pCI vector. The ligation reaction system is shown in Table 4, and the reaction was carried out at 25°C for 15 min to form the full-length genomic plasmid pCI-LaSota( Figure 3 ).
[0056] Table 2 Enzyme digestion system
[0057]
[0058] Table 3 Ligation reaction system
[0059]
[0060] Example 2 Auxiliary plasmid construction
[0061] The cDNA obtained in Example 1 was used as a template to PCR amplify the CDS regions of the N and P genes. In view of the slightly longer length of the L gene, it was amplified in two sections (L1 and L2) according to the XmaⅠ restriction enzyme site in the L gene, and the Kozak sequence (GCCACC) was introduced upstream of the CDS region of each gene to enhance the expression of the target protein. NheⅠ and NotⅠ restriction sites were introduced at both ends of the NP and P genes, respectively, and XbaⅠ and NotⅠ restriction sites were introduced at both ends of the L gene. The obtained target fragments were connected to the TA / Blunt-Zero cloning vector (C601-01), transformed into DH5α competent cells, and the positive single colony was picked to extract the plasmid. After identification, it was connected to the multiple cloning site of the pCI expression vector, and recorded as pCI-NP, pCI-P, and pCI-L.
[0062] Table 4 Primers used for auxiliary plasmid construction
[0063]
[0064]
[0065] Note: The underlined part indicates the restriction site; the bold part indicates the Kozak sequence
[0066] The NP gene and the PolyA tail part connected to it were amplified by PCR, and this part was recorded as NP-PolyA. Then, the CMV part was amplified separately by PCR, and the CMV part was connected to the 3' end of NP-PolyA by fusion PCR to form an NP-PolyA-CMV structure. The modification method of the P gene was the same as that of NP to obtain the P-PolyA-CMV structure. The MluⅠ restriction site was introduced upstream of the NP-PolyA-CMV structure, and the SacⅡ restriction site was introduced downstream. The SacⅡ restriction site was introduced upstream of the P-PolyA-CMV structure, and the XbaⅠ restriction site was introduced downstream. The recovered PCR product was connected to the pEASY-Blunt cloning vector for sequencing. After correct identification, it was digested with the corresponding restriction sites. The NP-PolyA-CMV structure and the P-PolyA-CMV structure were connected to the pCI-L vector MluⅠ, SacⅡ, and XbaⅠ in sequence by T4 ligase to construct a three-promoter expression vector pCI-NPL, such as Figure 4 shown.
[0067] In order to verify the correct construction of the plasmid, according to the restriction sites introduced at both ends of the CDS region of each protein, the pCI-NP and pCI-P plasmids were digested with NheⅠ and NotⅠ, and the pCI-L plasmid was digested with XbaⅠ and NotⅠ. Figure 5 ), it can be clearly observed that there are obvious bands at around 3942bp (pCI), 1477bp (NP), 1195bp (P), and 6628bp (L), which are consistent with expectations, indicating that the three auxiliary plasmids were successfully constructed. MluⅠ, SacⅡ, SacⅡ, XbaⅠ were used for double enzyme digestion verification and sequencing, and obvious bands were observed at 2710bp, 2442bp, and 3977bp (pEASY-Blunt vector) ( Figure 6 ), which is consistent with the expected NP-PolyA-CMV and P-PolyA-CMV parts. According to the above restriction sites, they were sequentially connected to the multiple cloning sites of the pCI-L plasmid to construct pCI-NPL. According to the unique restriction sites MluⅠ and StuⅠ on the plasmid, the plasmid was correctly connected and could be cut into two fragments of 10605bp and 5132bp in size respectively ( Figure 7 ), which is consistent with the prediction results of snapgene software.
[0068] Example 3 Auxiliary plasmid identification
[0069] 1. Indirect immunofluorescence detection of auxiliary plasmid expression
[0070] Well-growing BHK-21 cells were plated on 24-well cell plates for overnight culture. Lipofectamine 3000 liposome transfection reagent (Thermo Fisher, L3000075) was used to transfect pCI-NP, pCI-P, pCI-L, and pCI-NPL into the 24-well plate cells. According to the instructions, 7.5 μL L3000 reagent was diluted with 125 μL Opti-MEM medium, and 2.5 μg of each DNA plasmid and 5 μL P3000 reagent were diluted with 125 μL Opti-MEM medium. The two dilutions were mixed at 1:1 and incubated at room temperature for 15 min, added to BHK-21 cells, and cross-shaken to evenly distribute the transfection products on the cell surface. The cells were placed in a 5% CO2, 37°C cell culture incubator for culture. After transfection for 24 hours, the culture medium in the cell plate was discarded, washed twice with PBS, fixed with 80% cold acetone for 30 min, acetone was discarded, and washed three times with PBS. TBST buffer containing 1% BSA was prepared, and mouse NP protein monoclonal antibody was diluted at 1:1000, rabbit P protein antiserum was diluted at 1:2000, and chicken L protein antiserum was diluted at 1:2000 as primary antibody, and incubated at room temperature on a shaker for 1 hour. The antibody diluent was discarded, and the cells were washed 3 times with PBST. Alexa Fluor 555-labeled donkey anti-mouse antibody (Biyuntian, A0460), FITC-labeled goat anti-rabbit IgG (H+L) (Biyuntian, A0562) and FITC-labeled goat anti-chicken IgG (bioss, bs-0310G) fluorescent secondary antibodies were diluted 1:500 with 1% BSA TBST buffer, and incubated at room temperature on a shaker for 1 hour under light-proof conditions. 4',6-diamidino-2-phenylindole (DAPI) staining reagent was used to stain the cell nucleus for 5 minutes, and the intracellular fluorescence signal was observed under a Leica upright fluorescence microscope after washing 3 times with PBST.
[0071] Under a fluorescence microscope, the wells transfected with pCI-NP cells showed obvious red fluorescence, while the wells transfected with pCI-P and pCI-L cells showed green fluorescence ( Figure 8). It was proved that pCI-NP, pCI-P, and pCI-L can express the corresponding NP, P, and L proteins and can be specifically recognized by the corresponding primary antibodies. In order to identify the auxiliary plasmid pCI-NPL that co-expresses NP, P, and L, it was first verified that the pCI-NPL plasmid simultaneously expresses NP and P proteins. The cell wells transfected with pCI-NPL used mouse NP monoclonal antibody and rabbit anti-P protein antibody as primary antibodies, and Alexa Fluor 555-labeled goat anti-mouse antibody and FITC-labeled goat anti-rabbit antibody as secondary antibodies for indirect fluorescence staining. Red and green fluorescence signals were observed simultaneously in cells transfected with pCI-NPL, while only blue nuclear signals were observed in untransfected cells. Next, it was verified that the pCI-NPL plasmid simultaneously expresses NP and L proteins. The cell wells transfected with pCI-NPL used mouse NP monoclonal antibody and chicken anti-L protein antibody as primary antibodies, and Alexa Fluor 555-labeled goat anti-mouse antibody and FITC-labeled goat anti-chicken antibody as secondary antibodies for indirect fluorescence staining. Red and green fluorescence signals were observed simultaneously in cells transfected with pCI-NPL ( Fig. 9 ).
[0072] 2. Western blot detection of auxiliary plasmid expression
[0073] BHK-21 cells with good growth were inoculated into six-well cell plates, and pCI-NP, pCI-P, pCI-L, and pCI-NPL plasmids were transfected with Lipofectamine 3000 liposome transfection reagent when the cell confluence reached 80%, and the steps were as described above. After transfection for 48 hours, the six-well plates were washed twice with PBS and RIPA lysis buffer (RIPA: protease inhibitor: EDTA = 98:1:1) was added, and the cells were collected into a 1.5 mL centrifuge tube using a cell scraper, incubated at 4°C shaker for 20 minutes, and centrifuged at 4°C 12000 rpm for 10 minutes to collect the supernatant. According to the instructions of the BCA protein concentration determination kit, the protein sample concentration was calculated and adjusted to be consistent. After adding 4× loading buffer and boiling for 10 minutes, SDS-PAGE electrophoresis was performed. After the electrophoresis, the protein was transferred from the polyacrylamide gel to the NC membrane and placed in 5% skim milk powder for blocking at room temperature on a shaker for 1 hour. PBST (PBS containing 0.05% Tween20) was washed 3 times. NP, P, and L proteins were incubated with corresponding mouse NP protein antibodies, rabbit P protein antibodies, and chicken L protein antibodies at 4°C overnight, washed 3 times with PBST, and horseradish peroxidase (HRP)-labeled goat anti-mouse IgG, anti-rabbit IgG, and anti-chicken IgG secondary antibodies were diluted with antibody diluent at 1:2000 and incubated at room temperature on a shaker for 1 hour. After washing the NC membrane three times with PBST, the A solution and B solution in the ECL chemiluminescence kit (Biyuntian, P0018AFT) were mixed 1:1 and then dropped onto the surface of the NC membrane, and placed in an ultra-sensitive multifunctional imager (AI600) for exposure and development.
[0074] The results of western blot detection of auxiliary plasmid protein expression showed that the samples transfected with pCI-NP and pCI-NPL were incubated with mouse NP protein monoclonal antibody as primary antibody and HRP-labeled goat anti-mouse IgG as secondary antibody, and the results showed that a specific band of 53 kDa was observed; the samples transfected with pCI-P and pCI-NPL were incubated with rabbit anti-P protein antibody and HRP-labeled goat anti-rabbit secondary antibody, and a specific band of 42 kDa was observed; and the samples transfected with pCI-L and pCI-NPL were detected with chicken L protein antibody and HRP-labeled goat anti-chicken antibody as secondary antibody, and the results showed that a specific band of 248 kDa was observed ( Fig.10 ). This indicates that pCI-NPL plasmid simultaneously expresses NP, P, and L proteins in BHK-21 cells.
[0075] Example 4 Construction of NDV dual plasmid rescue system
[0076] Prepare well-grown BHK-21 cells and inoculate them on a 6-well plate for overnight culture, and transfect them when the cell confluence is about 60%. According to the instructions of the calcium phosphate transfection kit (Invitrogen, K278001), take 5μg pCI-LaSota, 2.5μg pCI-NPL and 9μL CaCl2 solution and add them to a 1.5ml centrifuge tube, add sterile H2O to 75μL, invert and mix, and gradually transfer to the pre-prepared 2×Hepes Buffered Saline in small amounts and multiple times, and blow dense small bubbles into the centrifuge tube continuously for about 2.5 minutes. After all the mixtures were mixed, they were allowed to stand for 20 minutes, added to a BHK-21 six-well cell plate, and cross-shaked to evenly distribute the transfection mixture on the cell surface. The cells were cultured in a 5% CO2, 37°C incubator for 3 hours, then placed in a 42°C water bath for 2 hours of heat shock, and continued to be cultured in a cell incubator. After 24 hours of transfection, the culture medium was discarded, and PBS buffer containing 10% DMSO was added for cell shock. After 2.5 minutes, the liquid was discarded, and complete DMEM culture medium was added to continue culturing in the incubator. After 48 hours of transfection, serum-free DMEM was replaced and 2 μL TPCK trypsin (1 μg / mL) was added. After 96 hours of transfection, the cell supernatant was harvested, filtered through a 0.22 μM filter, and inoculated into the allantoic cavity of 9-11-day-old SPF chicken embryos. After 120 hours, the chicken embryo allantoic fluid was collected for hemagglutination (HA) test. The chicken embryo allantoic fluid was subjected to 2 1 -2 11 The 1% chicken red blood cells were added to the 96-well V-type hemagglutination plate at 50 μL / well, and then 1% chicken red blood cells were added at 50 μL / well. After standing for 30 minutes, it was observed that 2 1 -2 7The red blood cells in the diluted samples showed agglutination, while the red blood cells in the allantoic fluid inoculated with normal cell supernatant were observed to flow in a teardrop shape ( Fig.11 ), proving that a recombinant Newcastle disease virus with hemagglutination effect was successfully rescued, with a hemagglutination titer of 7log2, named rLaSota, and stored at -80℃ for future use.
[0077] Example 5 Virus RT-PCR Identification
[0078] In order to identify the correctness of the rescued virus, the allantoic fluid of chicken embryos containing rLaSota and WT (wild type) LaSota genomic RNA were extracted in Example 4, and cDNA was obtained by reverse transcription. Primers Pme-PF and Pme-PR (primer sequences are shown in Table 5) were designed to perform PCR amplification on 499 bp on both sides of the PmeⅠ restriction site of rLaSota virus. After recovery, the fragments were digested with PmeⅠ, and the results showed that the fragments amplified in rLaSota could be digested by PmeⅠ restriction endonuclease into two fragments of 209 bp and 290 bp in size, while the wild type strain could not be cut because it did not contain PmeⅠ site ( Fig.12 ), which was exactly the same as the expected result. In order to exclude the possibility of residual contamination from plasmid transfection, the extracted RNA sample was directly subjected to PCR using the PmeⅠ identification primer, and no bands were amplified, eliminating the possibility of false positives from plasmid contamination. At the same time, the PCR product was sequenced to identify the nucleotide sequence of the molecular genetic marker site. The results showed that the 3155-3162nt sequence of the rescued virus rLaSota genome was changed to the PmeⅠ restriction site sequence, while the wild-type strain genome sequence was unchanged, indicating that the recombinant virus rLaSota was successfully rescued, and the constructed dual-plasmid rescue system was feasible and effective.
[0079] Table 5 Primers used for virus identification
[0080]
[0081] Example 6 Virus indirect immunofluorescence
[0082] In order to further identify the virus rescued, the BHK-21 cells with good growth condition were inoculated in 24-well plates for overnight growth, the chicken embryo allantoic fluid of the results was infected with BHK-21 cells by MOI=1, and was placed in 37 ℃ of 5% CO2 incubator for 1h, and the supernatant was abandoned and the culture medium of 5% serum was changed to continue to cultivate. After 24h, the culture medium was abandoned, and PBS was cleaned twice and fixed with 80% cold acetone for 30min, and the TBST buffer containing 1% BSA was diluted 50 times for chicken anti-NDV serum as an antibody, and the shaking table was incubated for 1h at room temperature, and PBST was washed three times, 5min / time, and the FITC-labeled goat anti-chicken fluorescent secondary antibody of 2000 times of dilution was added, 100 μL / well, and it was placed on a shaking table and incubated at room temperature for 1h under lucifuge, and PBST was cleaned three times, and a small amount of PBS was added to observe whether the cells present green fluorescence under a fluorescence microscope. The results showed that both rLaSota and WT LaSota could be specifically recognized by NDV positive serum, showing strong green fluorescence signals under fluorescence microscope, while the samples detected by SPF chicken embryo serum as primary antibody showed no fluorescence signals ( Fig.13 ).
[0083] Example 7 Virus Pathogenicity Detection
[0084] 1. rLaSota chicken embryo mean lethal time (MDT) test
[0085] Thaw the previously stored rLaSota allantoic fluid on ice and dilute it to 10% with sterile saline. -1 -10 -9 , 5 allantoic cavities of 9-11 day old SPF chicken embryos were inoculated with each dilution of allantoic fluid, 100 μL / egg. Eggs were candled twice a day for 7 consecutive days, the death time of each chicken embryo was recorded, and the MDT value was calculated.
[0086] 2. rLaSota intracerebral pathogenicity index (ICPI) test
[0087] The virus allantoic fluid was diluted 10 times with sterile saline and inoculated intracerebrally into 10 SPF chicks 24 to 40 hours after hatching, with an inoculation volume of 0.05 mL / chicken. The chickens were observed and scored every day, with the normal chicken value recorded as 0, the diseased chicken value recorded as 1, and the dead chicken value recorded as 2. The observation was continued for 8 days, and the ICPI value was calculated according to the OIE standard and compared with WT LaSota.
[0088] 3. rLaSota venous pathogenicity index (IVPI) test
[0089] Ten 6-week-old SPF chickens were selected, and the rLaSota virus allantoic fluid was diluted 10 times with sterile saline. 0.2 mL was inoculated intravenously in each chicken. The incidence and mortality were observed within 10 days after inoculation, and the IVPI value was calculated according to the OIE standard.
[0090] The average lethal time of chicken embryos, the pathogenicity index of intracerebral inoculation, and the pathogenicity index of intravenous inoculation were determined according to the OIE standard and the results are shown in Table 6. The MDT of rLaSota was greater than 120h, and the ICPI and IVPI were both 0, which was basically consistent with the pathogenicity of WT LaSota. The results showed that rLaSota still retained the low pathogenicity characteristics of wild-type LaSota.
[0091] Table 6 Determination of pathogenicity indexes of WT LaSota and rLaota
[0092]
[0093] Example 8 Virus Chicken Embryo Growth Characteristics
[0094] The rescued rLaSota strain and WT LaSota virus were respectively cultured at 1×10 4 EID50 was inoculated into the allantoic cavity of chicken embryos, and the allantoic fluid was collected from 6 chicken embryos at 24h, 48h, 72h, and 96h for 10-fold series gradient dilution. Four chicken embryos were inoculated at each dilution, 0.1mL / piece, and dead chicken embryos within 24h were discarded. After 5 days, the allantoic fluid of chicken embryos was collected for hemagglutination (HA) activity detection, and the EID50 was calculated using the Reed-Muench method. The average EID50 per milliliter of rLaSota allantoic fluid was calculated to be 10 8.25 , 10 8.91 , 10 9.3 , 10 9.02 , EID50 of WT laSota allantoic fluid was 10 8.4 , 10 8.79 , 10 9.42 and 10 9.18 ( Fig.14 ), indicating that although the growth rate of rLaSota was slightly lower than that of the wild strain, the final virus titer could still grow to 10 9 , with chicken embryo growth characteristics similar to those of the wild-type strain.
[0095] Example 9 Evaluation of the efficiency of the dual plasmid rescue system
[0096] The enhanced green fluorescent protein (EGFP) expression cassette was cloned, including a transcription termination signal (TTAGAAAAAA), a transcription start signal (ACGGGTAGAA) and the EGFP gene ORF, and inserted into the NDV full-length cDNA cloning plasmid pCI-LaSota through the PmeⅠ restriction site to construct the transcription plasmid pCI-LaSota-EGFP.
[0097] To evaluate the rescue efficiency of the two-plasmid rescue system, the two-plasmid system consisting of pCI-LaSota-EGFP and pCI-NPL was co-transfected into BHK-21 cells in a 12-well cell culture plate at a ratio of 1:1 by calcium phosphate transfection method, 10 μg / well, for a total of 10 cell wells. At the same time, the four-plasmid rescue system consisting of pCI-LaSota-EGFP and pCI-NP, pCI-P, and pCI-L was co-transfected into BHK-21 cells in a 12-well cell culture plate at a ratio of 4:2:1:1, and the total amount of plasmids was also 10 μg / well, for a total of 10 cell wells. 3 hours after transfection, heat shock the cells in a 42°C water bath for 2 hours. After continued culture for 12 hours, shock the cells with PBS containing 10% DMSO for 2.5 minutes, discard the shock solution, add complete DMEM and continue culture for 24 hours. Replace the maintenance solution with 2% serum DMEM, add 1μLTPCK trypsin (1μg / mL), and observe the presence of green fluorescent protein signal under a fluorescence microscope every day.
[0098] like Fig.15 As shown, three days after transfection, bright green fluorescence was observed in nine wells of the double plasmid group, and the rescue efficiency was 90%; while only one well of the four plasmid group had weak green fluorescence. Four days after transfection, a large number of cytopathic death was observed in the double plasmid group, while there was no obvious cytopathic death in the four plasmid group, but green fluorescence signals were observed in four cell wells cumulatively, and the rescue efficiency was 40%. Five days after transfection, all cells died and fell off. This shows that the efficiency of the constructed NDV double plasmid rescue system is 2.25 times that of the traditional four plasmid system.
Claims
1. A method for constructing a Newcastle disease virus double plasmid rescue system, characterized in that: The following steps are involved: S1. Construction of plasmid pCI-LaSota for full-length cloning of the genome of Newcastle disease virus LaSota strain: According to the genome sequence of Newcastle disease virus LaSota strain, the whole genome was divided into 5 gene fragments with overlapping ends and cloned in segments, and the restriction enzyme sites of the overlapping parts of adjacent fragments were used to splice in vitro into the complete NDV LaSota strain genome full-length cDNA, and the hammerhead ribozyme sequence and hepatitis delta virus ribozyme sequence were introduced at the 5' end and 3' end, respectively, and cloned into the eukaryotic expression vector pCI to construct pCI-LaSota, whose nucleotide sequence is shown in SEQ No.1; The genome of the Newcastle disease virus LaSota strain was first mutated by PCR site-directed mutagenesis to mutate the 3155-3162nt sequence into a PmeⅠ restriction enzyme sequence, and then the LaSota genome was divided into five gene fragments according to the restriction sites PmeⅠ, XbaⅠ, BsiWⅠ, and StuⅠ in the genome, and the amplified products of the five gene fragments were 3216bp, 3014bp, 2680bp, 3985bp, and 2437bp fragments, respectively; the primer sequences used for the five gene fragments F1-F5 were shown in SEQ No.3 to SEQ No.14; an MluⅠ restriction enzyme site was introduced upstream of the hammerhead ribozyme sequence, and a NotⅠ restriction enzyme site was introduced downstream of the hepatitis D virus ribozyme sequence, and the entire genome was connected to the MluⅠ and NotⅠ sites downstream of the CMV promoter of the pCI eukaryotic expression vector using the MluⅠ and NotⅠ restriction sites to construct the full-length genome plasmid pCI-LaSota; S2. Construction of auxiliary plasmid PCI-NPL: Using the cDNA in step S1 as a template, NP, P and L genes were amplified respectively, and the promoter CMV and Poly A signal were fused to construct a three-promoter auxiliary plasmid PCI-NPL that can co-express NP, P and L proteins, and its nucleotide sequence is shown in SEQ No. 2; The cDNA in step S1 is used as a template to amplify the CDS regions of NP and P genes respectively, the L gene is amplified by dividing it into two segments L1 and L2 according to the XmaⅠ restriction enzyme site in the L gene, and the Kozak sequence GCCACC is introduced upstream of the CDS region of each gene; NheⅠ and NotⅠ restriction enzyme sites are introduced at both ends of the NP and P genes, respectively, and XbaⅠ and NotⅠ restriction enzyme sites are introduced at both ends of the L gene; the amplified NP, P and L genes are connected to the multiple cloning site of the pCI expression vector, respectively, and are recorded as pCI-NP, pCI-P, and pCI-L; the NP and P genes are then connected to PolyA, respectively, to obtain NP-PolyA and P-PolyA, and the fusion PCR method is used to obtain the NP-PolyA and P-PolyA. The method comprises the following steps: connecting the CMV part to the 3' end of NP-PolyA and P-PolyA, respectively, to form NP-PolyA-CMV and P-PolyA-CMV structures; introducing an MluⅠ restriction site upstream and a SacⅡ restriction site downstream of the NP-PolyA-CMV structure, introducing a SacⅡ restriction site upstream and a XbaⅠ restriction site downstream of the P-PolyA-CMV structure, digesting with corresponding restriction endonucleases, and sequentially connecting the NP-PolyA-CMV structure and the P-PolyA-CMV structure to the pCI-L vector MluⅠ, SacⅡ, and XbaⅠ using T4 ligase to construct a three-promoter auxiliary plasmid pCI-NPL; S3. Construction of dual-plasmid rescue system: The full-length cloning plasmid pCI-LaSota of the LaSota strain of Newcastle disease virus and the auxiliary plasmid PCI-NPL were co-transfected into BHK-21 cells at a ratio of 2:1 by the calcium phosphate method. The supernatant of the transfected cells was harvested 5 days later and inoculated into the allantoic cavity of SFP chicken embryos. The virus allantoic fluid was harvested and the positive result of the HA test was recorded as rLaSota for storage. The construction method of the dual plasmid rescue system is: Take 5 μg pCI-LaSota, 2.5 μg pCI-NPL and 9 μL 2M CaCl2 solution and add them to a 1.5 ml centrifuge tube. Add sterile H2O to 75 μL, invert and mix well. Transfer the mixture into 75 μL 2×Hepes Buffered Saline; after all the mixtures were mixed and allowed to stand for 20 minutes, the mixture was added to a BHK-21 six-well cell plate to evenly distribute the transfection mixture on the cell surface. The cells were cultured in a 5% CO2, 37°C incubator for 3 hours, then placed in a 42°C water bath for 2 hours of heat shock, and continued to be cultured in a cell incubator; 24 hours after transfection, the culture medium was discarded, PBS buffer containing 10% DMSO was added for cell shock, the solution was discarded after 2.5 minutes, and complete DMEM culture medium was added to continue culturing in the incubator; 48 hours after transfection, serum-free DMEM was replaced and TPCK trypsin was added to a final concentration of 1 μg / mL; 96 hours after transfection, the cell supernatant was harvested, filtered through a 0.22 μM filter, and inoculated into the allantoic cavity of 9-11-day-old SPF chicken embryos; 120 hours later, the chicken embryo allantoic fluid was collected for hemagglutination test, and the chicken embryo allantoic fluid was subjected to 2 1 -2 11 The 1% chicken red blood cells were added to the 96-well V-type hemagglutination plate at 50 μL / well, and then 1% chicken red blood cells were added at 50 μL / well. After standing for 30 minutes, it was observed that 2 1 -2 7 Red blood cells showed agglutination in the diluted samples, while red blood cells were observed to flow in a teardrop shape in the chicken embryo allantoic fluid inoculated with normal cell supernatant. For those with positive test results, the hemagglutination titer of the recombinant Newcastle disease virus reached 7log2, which was recorded as rLaSota.
2. A Newcastle disease virus double plasmid rescue system, characterized in that, Obtained by the construction method described in claim 1.
3. the identification method of Newcastle disease virus double plasmid rescue system as claimed in claim 2, is characterized in that, The double plasmid system consisting of transcription plasmid pCI-LaSota-EGFP and pCI-NPL was co-transfected into BHK-21 cells at a ratio of 1:1 by calcium phosphate transfection method. After 3 hours of transfection, the cells were placed in a 42°C water bath for heat shock for 2 hours. After continued culture for 12 hours, the cells were shocked with PBS containing 10% DMSO for 2.5 minutes, the shock solution was discarded, and complete DMEM was added to continue culture for 24 hours. The maintenance solution was replaced with 2% serum DMEM, and 1 μL of TPCK trypsin at a concentration of 1 μg / mL was added. The presence of green fluorescent protein signal was observed under a fluorescence microscope every day. The method for constructing the transcription plasmid pCI-LaSota-EGFP is as follows: clone an expression cassette consisting of a transcription termination signal TTAGAAAAAA, a transcription start signal ACGGGTAGAA and an enhanced green fluorescent protein gene ORF, and insert it into the PmeⅠ restriction site between PM genes in the full-length cloning plasmid pCI-LaSota of the Newcastle disease virus LaSota strain genome to construct the transcription plasmid pCI-LaSota-EGFP.
